AdvaMed Privacy Comments Will Seek Clarity On PHI Disclosure Procedure
This article was originally published in The Gray Sheet
Executive Summary
HHS should clarify whether or not protected health information can be released to foreign governments without the permission of FDA under HIPAA privacy guidelines, AdvaMed says